Effect of Tourniquet Application on Optic Nerve Sheath Diameter
The Effect of Tourniquet Application on Optic Nerve Sheath Diameter and Cerebral Oxygenation During Lower Extremity Surgery
1 other identifier
observational
1
1 country
1
Brief Summary
The aim of the study to investigate the effect of tourniquet application on optic nerve sheath diameter (ONSD) and cerebral oxygenation during lower extremity surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 8, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedFebruary 17, 2021
February 1, 2021
8 months
February 8, 2021
February 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
optic nerve diameter
measuring the change in optic nerve diameter
during the surgery
regional cerebral oxgenation
measurement rSo2 by Near Infrared spectroscopy
during the surgery
Eligibility Criteria
lower extremity surgery with tourniquet
You may qualify if:
- ASA I-II risk group over the age of 18
- Operation planned under general anesthesia
- Lower extremity surgery with a tourniquet
- Agreeing to volunteer for research with an informed consent form
You may not qualify if:
- Emergency surgical procedures
- neurological disease, carotid disease
- Previous intracranial or ocular surgery
- Neurological symptoms
- cerebral edema, high IntraCranial Pressure
- Presence of glaucoma
- Body mass index (BMI)\> 35
- Uncontrolled hypertension
- Diabetic retinopathy
- anemia
- coronary artery disease
- peripheral artery disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bülent Ecevit University Medicine Faculty
Zonguldak, Kozlu, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
February 8, 2021
First Posted
February 17, 2021
Study Start
April 15, 2019
Primary Completion
December 15, 2019
Study Completion
June 1, 2020
Last Updated
February 17, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share